As powerful new obesity drugs enter the US market, medical associations are keen to advise their members on how to best use them for patients. That is where the debate begins. Some specialists advocate for the broad use of drugs like Novo Nordisk's Wegovy, alongside a healthy diet and exercise. Others reco
(Reuters) - As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. That is where the debate begins. | 11:22am
As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. That is where the debate begins.